登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
CH3CH(NH2)CH2OH
化学文摘社编号:
分子量:
75.11
UNSPSC Code:
12352116
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1718866
Assay:
98%
assay
98%
optical activity
[α]19/D −18°, neat
optical purity
ee: 97% (GLC)
refractive index
n20/D 1.4493 (lit.)
bp
166-168 °C (lit.)
density
0.963 g/mL at 20 °C (lit.)
functional group
amine, hydroxyl
SMILES string
C[C@@H](N)CO
InChI
1S/C3H9NO/c1-3(4)2-5/h3,5H,2,4H2,1H3/t3-/m1/s1
InChI key
BKMMTJMQCTUHRP-GSVOUGTGSA-N
General description
(R)-(-)-2-氨基-1-丙醇是手性仲胺。
Application
在通过高效液相色谱分析棉籽中棉酚对映体的过程中,(R)-(-)-2-氨基-1-丙醇已被用作棉酚的衍生化试剂。
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Skin Corr. 1B
存储类别
8A - Combustible corrosive hazardous materials
wgk
WGK 3
flash_point_f
181.4 °F - closed cup
flash_point_c
83 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer.
Schelman WR, et al.
Investigational New Drugs, 32(2), 295-302 (2014)
Determination of (+)-,(-)-, and total gossypol in cottonseed by high-performance liquid chromatography.
Hron RJ, et al.
Journal of the American Oil Chemists' Society, 76(11), 1351-1355 (1999)
William R Schelman et al.
Investigational new drugs, 32(2), 295-302 (2013-07-19)
A phase I, dose-escalation study of AT-101 with cisplatin and etoposide was conducted to determine the maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D), safety and pharmacokinetics in patients with advanced solid tumors, with an expanded cohort in patients with
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 297682-5G | 04061837639821 |
| 297682-1G | 04061826656860 |
